1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
US8877733B2 · kind B2 · utility
46Cited by
2References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2012 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Apr 19, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of Formula I:nucleosides, nucleoside phosphates and prodrugs thereof, wherein R6 is CN, ethenyl, 2-haloethen-1-yl, or (C2-C8)-alkyn-1-yl. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.